The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews
It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.
(Image credit: Osodi Emmanuel)
BlogZone shows headlines and summaries from public news feeds. The full story is published by NPR News.
Read the full story at NPR News →Enjoyed this?
Get more stories like this — and write your own — in the BlogZone app.

